EIF1AX/RAS-mutated tumours with either TERT promoter or TP53 mutations are larger and aggressive with early metastasis and confer worse survival in PDTCs and ATCs [82]. Here, TP53 is linked to Ehlers-Danlos syndrome, musculocontractural type.